MyFinsight
Home
Blog
About
Contact
In-process research and
development, net of...
$90,506,250
Goodwill
$9,346,796
Deferred financing costs
$169,252
Deposits
$38,062
Inventory
$22,659,590
Cash and cash
equivalents
$4,590,174
Prepaid expenses
$3,356,882
Accounts receivable, net
of allowances
$1,079,055
Total other assets
$100,060,360
Total current assets
$31,685,701
Operating lease
right-of-use asset, net
$794,518
Total assets
$132,540,579
Total liabilities and
equity
$132,540,579
Total equity
$69,084,553
Total liabilities
$63,456,026
Total citius
pharmaceuticals, inc....
$61,541,536
Non-controlling interest
$7,543,017
Total current
liabilities
$55,015,569
Deferred tax liability
$7,803,790
Operating lease liability
noncurrent
$636,667
Accumulated deficit
-$268,256,054
Additional paid-in capital
$329,775,214
Accrued expenses
$24,138,264
License payable
$17,650,000
Accounts payable
$9,453,803
Accrued compensation
$3,602,007
Operating lease liability
$171,495
Common stock - 0.001 par
value 250,000,000...
$22,376
Back
Back
Balance Sheet
Citius Pharmaceuticals, Inc. (CTXR)
Citius Pharmaceuticals, Inc. (CTXR)
source: myfinsight.com